Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies.

MLA

Mirantes, Cristina, et al. “Deletion of Pten in CD45-Expressing Cells Leads to Development of T-Cell Lymphoblastic Lymphoma but Not Myeloid Malignancies.” Blood, vol. 127, no. 15, Apr. 2016, pp. 1907–11. EBSCOhost, https://doi.org/10.1182/blood-2015-09-669036.

APA

Mirantes, C., Dosil, M. A., Hills, D., Yang, J., Eritja, N., Santacana, M., Gatius, S., Vilardell, F., Medvinsky, A., Matias-Guiu, X., & Dolcet, X. (2016). Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies. Blood, 127(15), 1907–1911. https://doi.org/10.1182/blood-2015-09-669036

Chicago

Mirantes, Cristina, Maria Alba Dosil, David Hills, Jian Yang, Núria Eritja, Maria Santacana, Sònia Gatius, et al. 2016. “Deletion of Pten in CD45-Expressing Cells Leads to Development of T-Cell Lymphoblastic Lymphoma but Not Myeloid Malignancies.” Blood 127 (15): 1907–11. doi:10.1182/blood-2015-09-669036.